Vepesid New Zealand - English - Medsafe (Medicines Safety Authority)

vepesid

link pharmaceuticals ltd - etoposide 100mg - capsule - 100 mg - active: etoposide 100mg excipient: citric acid monohydrate gelatin glycerol   iron oxide red macrogol 400 propyl hydroxybenzoate sodium ethyl hydroxybenzoate titanium dioxide water  

VEPESID etoposide 100mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

vepesid etoposide 100mg capsule blister pack

link medical products pty ltd t/a link pharmaceuticals - etoposide, quantity: 100 mg - capsule - excipient ingredients: iron oxide red; gelatin; purified water; glycerol; sodium propyl hydroxybenzoate; citric acid; sodium ethyl hydroxybenzoate; titanium dioxide; macrogol 400 - 1 - small cell carcinoma of the lung 2 - acutre monocytic and myelomoncytic leukaemia 3 - hodgkins disease 4 - non-hodgkins lymphoma indications as at 5 october 2000: in the treatment of: 1. small cell carcinoma of the lung. 2. acute monocytic and myelomonocytic leukaemia. 3. hodgkin's disease. 4. non-hodgkin's lymphoma.

VEPESID 100 mg capsule, soft Ireland - English - HPRA (Health Products Regulatory Authority)

vepesid 100 mg capsule, soft

bristol-myers squibb pharmaceuticals uc - etoposide - capsule, soft - 100 milligram(s) - podophyllotoxin derivatives; etoposide

VEPESID 100 mg capsule, soft Ireland - English - HPRA (Health Products Regulatory Authority)

vepesid 100 mg capsule, soft

cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 100 milligram(s) - podophyllotoxin derivatives; etoposide

VEPESID Etoposide 50mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

vepesid etoposide 50mg capsule blister pack

link medical products pty ltd t/a link pharmaceuticals - etoposide, quantity: 50 mg - capsule - excipient ingredients: sodium propyl hydroxybenzoate; glycerol; sodium ethyl hydroxybenzoate; citric acid; iron oxide red; gelatin; titanium dioxide; macrogol 400; purified water - 1 - small cell carcinoma of the lung 2 - acute monocytic and myelomonocytic leukaemia 3 - hodgkins disease 4 - non-hodgkins lymphonia indications as at 5 october 2000: in the treatment of: 1. small cell carcinoma of the lung. 2. acute monocytic and myelomonocytic leukaemia. 3. hodgkin's disease. 4. non-hodgkin's lymphoma.

Vepesid 100 mg soft caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vepesid 100 mg soft caps.

cheplapharm arzneimittel gmbh - etoposide 100 mg - capsule, soft - 100 mg - etoposide 100 mg - etoposide

Vepesid New Zealand - English - Medsafe (Medicines Safety Authority)

vepesid

link pharmaceuticals ltd - etoposide 50mg - capsule - 50 mg - active: etoposide 50mg excipient: citric acid monohydrate gelatin glycerol   iron oxide red macrogol 400 propyl hydroxybenzoate sodium ethyl hydroxybenzoate titanium dioxide water